NeuCyte and KIF1A.ORG Enter Collaboration Agreement

SAN CARLOS, Calif.: SAN CARLOS, Calif., Aug. 17, 2021 /PRNewswire/ -- NeuCyte, Inc., an innovative biotech company focused on developing novel treatments for neurological disorders, today announced that it has entered into a research collaboration agreement with KIF1A.ORG. This collaboration will focus on developing in vitro KAND models with a...

Click to view original post